JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B6621 DAMGO

Summary: μ opioid receptor agonist
B5111 DPDPE

Summary: Prototypical selective δ-opioid receptor agonist peptide

Soluble to 1 mg/mL
B6269 nor-Binaltorphimine dihydrochloride

Summary: κ-opioid receptor antagonist

<18.37 mg/mL
B6429 Naltrindole hydrochloride

Summary: δ opioid antagonist

Soluble in DMSO
B1534 AZD1981

Target: CRTH2

Summary: CRTh2 antagonist,potent and selective

insoluble in H2O; insoluble in EtOH; ≥19.8 mg/mL
B1519 Bazedoxifene HCl

Target: Estrogen and Related Receptors

Summary: Novel, non-steroidal, indole-based estrogen receptor modulator (SERM)

≥25.35 mg/mL
B1505 Epiandrosterone

Target: Voltage-gated Calcium Channels (CaV)

Summary: steroid hormone with weak androgenic activity
B1518 Erteberel (LY500307)

Target: Estrogen and Related Receptors

Summary: ERβ agonist, potent and selective

insoluble in H2O; ≥14.1 mg/mL
B1510 Medroxyprogesterone acetate

Target: Progesterone Receptors

Summary: Steroidal progestin
B1382 Anastrozole

Target: Aromatases

Summary: Aromatase inhibitor

insoluble in H2O; ≥14.15 mg/mL